What are the most important prognostic factors in patients with residual rectal cancer after preoperative chemoradiotherapy?
Background We aimed to establish robust histoprognostic predictors on residual rectal cancer after preoperative chemoradiotherapy (CRT). Methods Analyzing known histoprognostic factors in 146 patients with residual disease allows associations with patient outcome to be evaluated. Results The median...
Main Authors: | Sol-Min Kim, Ghilsuk Yoon, An Na Seo |
---|---|
Format: | Article |
Language: | English |
Published: |
Yeungnam University College of Medicine
2019-05-01
|
Series: | Yeungnam University Journal of Medicine |
Subjects: | |
Online Access: | http://yujm.yu.ac.kr/upload/pdf/yujm-2019-00157.pdf |
Similar Items
-
BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01) -
NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial)
by: Antoine Brouquet, et al.
Published: (2020-05-01) -
Role of Magnetic Resonance Imaging in Staging Rectal Carcinoma
by: Sitaram Barath, et al.
Published: (2017-04-01) -
The influence of the distal resection margin length on local recurrence and long- term survival in patients with rectal cancer after chemoradiotherapy and sphincter- preserving rectal resection
by: Grosek Jan, et al.
Published: (2017-05-01) -
A Nine-Gene Signature for Predicting the Response to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
by: In Ja Park, et al.
Published: (2020-03-01)